German-Catalan workshop on epigenetics and cancer

Epigenetics

Volumn 8, Issue 9, 2013, Pages 998-1003

  Vizoso, Miguel ^a   Esteller, Manel ^a,b,c  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Chromatin; DNA methylation; Epigenetics; Histone modifications; Non coding RNAs

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; DNA METHYLTRANSFERASE 3B; DOXORUBICIN; GEMCITABINE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 7; HISTONE H2A; HISTONE H3; HISTONE H4; HISTONE LYSINE METHYLTRANSFERASE; MITHRAMYCIN; SIRTUIN 2; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR ZEB1; UNTRANSLATED RNA; VORINOSTAT;

ARTICLE; BRAIN DAMAGE; CELL TRANSDIFFERENTIATION; COLORECTAL CANCER; CYTOARCHITECTURE; DNA METHYLATION; EPIGENETICS; GENETIC ASSOCIATION; GENOME; HEMATOPOIETIC CELL; HETEROCHROMATIN; HUMAN; LEUKEMIA; LOW DRUG DOSE; LUNG CANCER; LYMPHOMA; NEOPLASM; NEUROBLASTOMA; NONHUMAN; WORKSHOP;

CHROMATIN; DNA METHYLATION; EPIGENETICS; HISTONE MODIFICATIONS; NON-CODING RNAS;

ANTINEOPLASTIC AGENTS; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HISTONES; HUMANS; NEOPLASMS; PROGNOSIS; RNA, UNTRANSLATED;

EID: 84883525184     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.25856     Document Type: Article

References (31)

1. Witt O, Milde T, Deubzer HE, Oehme I, Witt R, Kulozik A, et al. Phase I/II Intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia. Klin Padiatr 2012; 224:398-403; PMID:22915450; http://dx.doi. org/10.1055/s-0032-1323692.
2. Oehme I, Linke JP, Böck BC, Milde T, Lodrini M, Hartenstein B. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc Natl Acad Sci USA 2013; 110:E2592-601; http://dx.doi. org/10.1073/pnas.1300113110.
3. Furdas SD, Shekfeh S, Bissinger EM, Wagner JM, Schlimme S, Valkov V, et al. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors. Bioorg Med Chem 2011; 19:3678-89; PMID:21353783; http://dx.doi. org/10.1016/j.bmc.2011.01.063.
4. Rius M, Stresemann C, Keller D, Brom M, Schirrmacher E, Keppler D, Lyko F. Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation. Mol Cancer Ther 2009; 8:225-31; PMID:19139132; http://dx.doi. org/10.1158/1535-7163.
5. Simó-Riudalbas L, Melo SA, Esteller M. DNMT3B gene amplification predicts resistance to DNA demethylating drugs. Genes Chromosomes Cancer 2011; 50:527-34; PMID:21484930; http://dx.doi. org/10.1002/gcc.20877.
6. Rodriguez-Paredes M, Martinez de Paz A, Simó-Riudalbas L, Sayols S, Moutinho C, Moran S, et al. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene 2013; PMID:23770855; http://dx.doi. org/10.1038/onc.2013.239.
7. Scherf DB, Sarkisyan N, Jacobsson H, Claus R, Bermejo JL, Peil B, et al. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene 2013; 32:3329-38; PMID:22945651; http://dx.doi. org/10.1038/onc.2012.344.
8. Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K, et al. Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB. PLoS Genet 2013; 9:e1003373; PMID:23593011 http://dx.doi.org/10.1371/journal. pgen.1003373.
9. Mertens D, Philippen A, Ruppel M, Allegra D, Bhattacharya N, Tschuch C, et al. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma 2009; 50:502-5; PMID:19347735; http:// dx.doi.org/10.1080/10428190902763509.
10. Gutschner T, Baas M, Diederichs S. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res 2011; 21:1944-54; PMID:21844124; http://dx.doi.org/10.1101/gr.122358.111.
11. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73:1180-9; PMID:23243023; http://dx.doi.org/10.1158/0008-5472.CAN-12-2850.
12. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12:861-74; PMID:22094949; http:// dx.doi.org/10.1038/nrg3074.
13. Ferreira HJ, Heyn H, Moutinho C, Esteller M. CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer. RNA Biol 2012; 9:881-90; PMID:22617881; http://dx.doi. org/10.4161/rna.19353.
14. Guil S, Soler M, Portela A, Carrère J, Fonalleras E, Gómez A, et al. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat Struct Mol Biol 2012; 19:664-70; PMID:22659877; http://dx.doi. org/10.1038/nsmb.2315.
15. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011; 30:770-82; PMID:21224848; http://dx.doi. org/10.1038/emboj.2010.349.
16. Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F, Esteller M. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012; 31:2062-74; PMID:21874049; http://dx.doi.org/10.1038/onc.2011.383.
17. Buschbeck M, Uribesalgo I, Wibowo I, Rué P, Martin D, Gutierrez A, et al. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat Struct Mol Biol 2009; 16:1074-9; PMID:19734898; http://dx.doi.org/10.1038/nsmb.1665.
18. Buschbeck M, Di Croce L. Approaching the molecular and physiological function of macroH2A variants. Epigenetics 2010; 5:118-23; PMID:20160488.
19. Creppe C, Janich P, Cantariño N, Noguera M, Valero V, Musulén E, et al. MacroH2A1 regulates the balance between self-renewal and differentiation commitment in embryonic and adult stem cells. Mol Cell Biol 2012; 32:1442-52; PMID:22331466; http://dx.doi. org/10.1128/MCB.06323-11.
20. Cantariño N, Douet J, Buschbeck M. MacroH2A-An epigenetic regulator of cancer. Cancer Lett 2013; 336:247-52; PMID:23531411; http://dx.doi. org/10.1016/j.canlet.2013.03.022.
21. Creppe C, Posavec M, Douet J, Buschbeck M. MacroH2A in stem cells: a story beyond gene repression. Epigenomics 2012; 4:221-7; PMID:22449192; http://dx.doi.org/10.2217/epi.12.8.
22. Posavec M, Timinszky G, Buschbeck M. Macro domains as metabolite sensors on chromatin. Cell Mol Life Sci 2013; 70:1509-24; PMID:23455074; http:// dx.doi.org/10.1007/s00018-013-1294-4.
23. Dryhurst D, McMullen B, Fazli L, Rennie PS, Ausió J. Histone H2A. Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression. Cancer Lett 2012; 315:38-47; PMID:22055461; http://dx.doi.org/10.1016/j.canlet. 2011.10.003.
24. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003; 13:1192-200; PMID:12867029.
25. Kamiyama H, Suzuki K, Maeda T, Koizumi K, Miyaki Y, Okada S, et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene 2012; 31:5029-5037; PMID:22310288; http://dx.doi.org/10.1038/onc.2011.652.
26. Vavouri T, Lehner B. Chromatin organization in sperm may be the major functional consequence of base composition variation in the human genome. PLoS Genet 2011; 7:e1002036; PMID:21490963; http://dx.doi. org/10.1371/journal.pgen.1002036.
27. Rodríguez-Ubreva J, Ciudad L, Gómez-Cabrero D, Parra M, Bussmann LH, di Tullio A, et al. Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. Nucleic Acids Res 2012; 40:1954-68; PMID:22086955; http:// dx.doi.org/10.1093/nar/gkr1015.
28. Kallin EM, Rodríguez-Ubreva J, Christensen J, Cimmino L, Aifantis I, Helin K, et al. Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells. Mol Cell 2012; 48:266-76; PMID:22981865; http:// dx.doi.org/10.1016/j.molcel.2012.08.007.
29. Barneda-Zahonero B, Román-González L, Collazo O, Rafati H, Islam AB, Bussmann LH, et al. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. Plos Genet 2013; 9:e1003503; PMID:23696748; http://dx.doi.org/10.1371/journal. pgen.1003503.
30. Petazzi P, Sandoval J, Szczesna K, Jorge OC, Roa L, Sayols S, et al. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. RNA Biol 2013; 10; PMID:23611944.
31. Serrano L, Martínez-Redondo P, Marazuela-Duque A, Vazquez BN, Dooley SJ, Voigt P, et al. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev 2013; 27:639-53; PMID:23468428; http://dx.doi.org/10.1101/ gad.211342.112.